Literature DB >> 8089469

Cytomegalovirus.

M A Smith1, D J Brennessel.   

Abstract

CMV is a common opportunistic pathogen in patients with AIDS and is a major source of morbidity in this population. CMV has been unequivocally implicated as a cause of increased mortality in immunosuppressed patients who do not have AIDS. Whether CMV directly causes higher mortality in the AIDS population, however, remains controversial. This review focuses on the major clinical syndromes caused by CMV infection. Studies are ongoing with regard to optimal dosing schedules using combination antiviral regimens. In addition, new drugs and vaccines are being investigated in an effort to better control, if not eliminate, CMV infection in AIDS patients.

Entities:  

Mesh:

Year:  1994        PMID: 8089469

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  5 in total

1.  Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection.

Authors:  J S Orange; T P Salazar-Mather; S M Opal; C A Biron
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

Review 2.  The risks and benefits of antimicrobial therapy in pregnancy.

Authors:  S M Garland; M A O'Reilly
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

Review 3.  Diagnosing HIV-related disease: using the CD4 count as a guide.

Authors:  A C Jung; D S Paauw
Journal:  J Gen Intern Med       Date:  1998-02       Impact factor: 5.128

4.  IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection.

Authors:  Branka Popovic; Mijo Golemac; Jürgen Podlech; Jelena Zeleznjak; Lidija Bilic-Zulle; Miodrag L Lukic; Luka Cicin-Sain; Matthias J Reddehase; Tim Sparwasser; Astrid Krmpotic; Stipan Jonjic
Journal:  PLoS Pathog       Date:  2017-04-27       Impact factor: 6.823

5.  Mycobacterial and nonbacterial pulmonary complications in hospitalized patients with human immunodeficiency virus infection: a prospective, cohort study.

Authors:  B Afessa
Journal:  BMC Pulm Med       Date:  2001       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.